News | Artificial Intelligence | February 08, 2024

Paige, a global provider of end-to-end digital pathology solutions and clinical artificial intelligence (AI) applications that assist in diagnosing cancer, has announced a significant expansion of its AppLab marketplace, with the addition of six new digital pathology and AI providers.

Paige deepens its AppLab's offerings by partnering with industry-leading third-party AI providers

Paige, a global provider of end-to-end digital pathology solutions and clinical artificial intelligence (AI) applications that assist in diagnosing cancer, has announced a significant expansion of its AppLab marketplace, with the addition of six new digital pathology and AI providers. Image courtesy: Paige.AI


February 8, 2024 — Paige, a global leader in end-to-end digital pathology solutions and clinical Artificial Intelligence (AI) applications that assist in diagnosing cancer, today announced a significant expansion of its AppLab marketplace, with the addition of six new digital pathology and AI providers. New applications from these industry-leading companies, including ImageneHistofyAiosynClinsightDoMore Diagnostics, and Stratipath*, will be added to the AppLab to provide support for pathology labs worldwide in building deeply integrated and customized AI-enabled workflows. 

The Paige AppLab is a comprehensive marketplace where, within a few clicks, pathologists can seamlessly browse, trial, and purchase a robust set of diagnostic support tools from various providers that can be then accessed in the Paige Platform and FullFocus viewer to support each unique step of cancer diagnosis.  The AppLab delivers full vendor-neutrality and flexibility to ensure labs are equipped with all the insights they need—from Paige or other partners—to efficiently meet the unique needs of their patients, now and in the future.  

The newly introduced applications unlock advanced AI-powered capabilities such as biomarker detection from H&E-stained slides, assistance with the grading and assessment of cancer across tissue types, risk-stratification, and more. Paige has worked closely with each AppLab vendor to ensure their technology is seamlessly integrated into the Paige Platform to simplify AI adoption and propel the practice of digital pathology forward.  

“We are excited to be part of Paige’s AppLab which ensures seamless and easy integration of AI solutions for end users. This is critical to bring innovation in the field forward,” said Torbjørn Furuseth, MD, Co-Founder and CEO of DoMore Diagnostics. “Paige will be a key partner as we continue to push the boundaries to personalize cancer treatment with our Histotype Px digital biomarkers.”  

Nasir Rajpoot, PhD, Co-Founder and Chief Scientific Officer of Histofy, added, "Paige AppLab allows Histofy a very exciting route for putting our groundbreaking AI solutions in the hands of a rapidly increasing number of pathologists and researchers using the Paige Platform. We are excited at the prospect of delivering our AI tools to market through Paige." 

Designed for real-world clinical utilization, Paige is committed to arming pathologists with the highest-quality products. Each new application can be trusted to work alongside Paige tools and applications to offer one powerful guidance engine that truly unlocks the full potential of digital pathology and AI. 

“We are excited to welcome these six additional industry-leading digital pathology vendors to the Paige AppLab. Their partnership serves as a testament to the innovative and cutting-edge technology Paige is built upon,” said Jill Sue, Vice President of Product, Paige. “With these vendor additions, the Paige AppLab serves as the one-stop-shop for all digital pathology needs.”  

*Stratipath breast is CE-IVD marked for clinical use 

For more information: https://paige.ai/


Related Content

News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | HIMSS

February 29, 2024 — The Healthcare Information Management Systems Society, HIMSS, recently announced it HIMSS 2024 ...

Time February 29, 2024
arrow
News | Artificial Intelligence

February 28, 2024 — DeepHealth, one of the leading providers of radiology informatics and AI solutions, and Incepto ...

Time February 28, 2024
arrow
News | Radiology Business

February 28, 2024 — Royal Philips has announced the proposal to appoint Charlotte Hanneman as member of the Board of ...

Time February 28, 2024
arrow
News | Women's Health

February 27, 2024 — Hologic, Inc. continues to deliver on its commitment to advancing women’s health by unveiling new ...

Time February 27, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it’s ...

Time February 27, 2024
arrow
News | Enterprise Imaging

February 26, 2024 — Hyland Healthcare, a leading global provider of intelligent content and enterprise imaging solutions ...

Time February 26, 2024
arrow
Feature | HIMSS | Christine Book

February 26, 2024 — This year’s Healthcare Information and Management Systems Society HIMSS Global Conference and ...

Time February 23, 2024
arrow
News | Radiology Imaging

February 23, 2024 — The American Society of Radiologic Technologists (ASRT) launched its "Be Seen" campaign today to ...

Time February 23, 2024
arrow
News | Breast Imaging

February 23, 2024 — ScreenPoint Medical is showcasing its industry leading Transpara Breast AI at the 2024 European ...

Time February 23, 2024
arrow
Subscribe Now